Prognosis in sudden hearing loss: Is it the disease or the treatment that determines the prognosis?

Simple item page
dc.contributor.buuauthorKasapoğlu, Fikret
dc.contributor.buuauthorTüzemen, Gökhan
dc.contributor.buuauthorHizalan, İbrahim
dc.contributor.buuauthorErişen, Levent
dc.contributor.buuauthorBasut, Oğuz İbrahim
dc.contributor.buuauthorOnart, Selçuk
dc.contributor.buuauthorCoşkun, Hakan
dc.contributor.buuauthorÖzmen, Ömer Afşin
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kulak Burun Boğaz Anabilim Dalı-Baş Boyun Cerrahisi.tr_TR
dc.contributor.orcid0000-0002-9698-0546tr_TR
dc.contributor.researcheridAAI-3877-2021tr_TR
dc.contributor.researcheridC-3960-2015tr_TR
dc.contributor.researcheridA-1452-2019tr_TR
dc.contributor.scopusid56254721200tr_TR
dc.contributor.scopusid30267939800tr_TR
dc.contributor.scopusid6506478628tr_TR
dc.contributor.scopusid6602590279tr_TR
dc.contributor.scopusid6602318367tr_TR
dc.contributor.scopusid7801637934tr_TR
dc.contributor.scopusid13610800100tr_TR
dc.contributor.scopusid55407733900tr_TR
dc.date.accessioned2022-03-08T06:24:26Z
dc.date.available2022-03-08T06:24:26Z
dc.date.issued2009
dc.description.abstractObjective: To compare the various treatment modalities for Sudden Hearing Loss (SHL) and to determine whether the prognosis depends upon the treatment or upon the disease itself. Materials and Methods: A total of 160 patients with SHL that were examined retrospectively between January 1995 and December 2006 were reviewed. Out of these, 115 patients, who a) presented within the first 15 days, b) completed monthly audiometric controls in the follow-up period and received c1) classical medical treatment (plasma volume expanders, vasodilators, diuretics, anti-aggregates, sedative agents and vitamin-B complex), c2) plus carbogen inhalation and/or c3) corticosteroid (systemic) therapy, c4) and/or intratympanic steroid therapy, were included into the study. Audiograms were received on the 5th 10th and 30th day of the treatment and hearing is compared based on "Pure Tone Averages" (PTA) at 500, 1000, 2000 and 4000 Hz. Results: Patients who received treatment within the first 5 days showed 35.2% improvement at PTA while others showed only 20.5% improvement (p=0.022). Patients with vertigo showed 18.2% mean percentile improvement in PTAs, whereas this recovery was 32.9% in the audiograms of the patients without vertigo (p=0.018). The percentile of improvement in PTAs was 49.7% for ascending type audiogram group which was significantly better than other groups (p=0.001). According to severity of hearing loss, recovery of mild hearing losses was higher, compared to other groups (p=0.018). A statistically significant difference was not detected between treatment modalities. Conclusions: All treatment methods used for the SHL provided certain degree of improvement in the audiometric measurements. But, the only statistically significant factor was the beginning of the therapy with in the first five days. Associated vertigo may have a negative effect on the outcome. Main prognostic factors were time of presentation, and presence of additional factors such as vertigo, severity of hearing loss and audiogram configurations, rather than the therapeutical agents used.en_US
dc.identifier.citationKasapoğlu, F. vd. (2009). "Prognosis in sudden hearing loss: Is it the disease or the treatment that determines the prognosis?". Journal of International Advanced Otology, 5(2), 187-194.en_US
dc.identifier.endpage194tr_TR
dc.identifier.issn1308-7649
dc.identifier.issue2tr_TR
dc.identifier.scopus2-s2.0-68049135882tr_TR
dc.identifier.startpage187tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/24887
dc.identifier.volume5tr_TR
dc.identifier.wos000267954400009tr_TR
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.journalJournal of International Advanced Otologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIntratympanic dexamethasoneen_US
dc.subjectHyperbaric-oxygenen_US
dc.subjectInner-earen_US
dc.subjectDeafnessen_US
dc.subjectEfficacyen_US
dc.subjectSteroidsen_US
dc.subjectOtorhinolaryngologyen_US
dc.subject.scopusSudden Hearing Loss; Perception Deafness; Steroiden_US
dc.subject.wosOtorhinolaryngologyen_US
dc.titlePrognosis in sudden hearing loss: Is it the disease or the treatment that determines the prognosis?en_US
dc.typeArticle

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
Scopus